Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

pharmacotherapy 4270 > 2. Chronic Non-Malignant Pain MT1 > Flashcards

2. Chronic Non-Malignant Pain MT1 Flashcards

1
Q

know the three factors that contribute to an individuals health based on the biopsychosocial model of pain

A

BIO
1. biology (e.g. pain)

PSYCHO
2. psychology (e.g. mental health treated helps with the pain)

SOCIAL
3. social context (e.g. social determinants of health)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the three main types of pain and any subtypes of those

A
  1. Acute pain (<30 days)
  2. subacute pain (1-3 mths)
  3. Chronic (>3mths)
    - nociceptive pain
    - neuropathic pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

this is a type of pain caused by damage to the body tissue; it usually feels sharp, aching or throbbing.

A

nociceptive pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

this type of pain can occur when your nervous system is injured or not working properly; it is often characterized as being a shooting or radiating pain

A

neuropathic pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are some factors that need to be considered when choosing a pain medication for a patient?

A
  • patient choice
  • cost, access, insurance coverage
  • patient characteristics (age, weight, renal/hepatic function, comorbidities)
  • severity/pattern of pain
  • type of pain/diagnosis
  • response to prior drugs
  • therapeutic drug monitoring
  • pharmacogenomics (drug receptors, drug metabolism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

know some examples of peripheral vs central neuropathic pain

A

PERIPHERAL
- carpal tunnel syndrome
- nerve trauma
- phantom limb pain
- peripheral neuropathies (e.g. HIV related, chemotherapy-induced, diabetic neuropathies)

CENTRAL
- central post-stroke pain
- spinal cord injury pain
- brain injury
- multiple sclerosis (MS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what do “SMART” treatment goals stand for?

A

S - specific!!!!!
M - measurable
A - action oriented
R - realistic
T - time bound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the first line options for management of neuropathic pain

A

VOLTAGE GATED ALPHA2 LIGAND
gabapentin/pregabalin

SERATONIN-NE REUPTAKE INHIBITORS (SNRI)
duloxetine/venlafaxine

SECONDARY AMINE TRICYCLIC ANTIDEPRESSANTS (TCA)
nortriptyline, amitriptyline)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the second line options for management of neuropathic pain?

A

Tramadol or opioid analgesics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the third line options for management of neuropathic pain?

A

Cannabinoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

If a first line agent for managing neuropathic pain is not quite successful, what are some options that may be considered before trying a second line option?

A
  • switch to another first line agent
  • try combining first line agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the three options when combining TCA’s, SNRI’s and gabepntinoids?

A
  1. TCA first then add pregabalin
  2. Pregabalin first then add TCA
  3. Duloxetine first then add pregabalin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the time to effectiveness for an optimal response at any particular dose of an analgesic?

A

2-4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When adding agent from another class to help increase analgesia, what should be monitored, especially when combining a TCA & SNRI?

A

adverse effects!!!!! combining TCA & SNRI can increase risk of serotonin syndrome!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

this is a first line agent for managing neuropathic pain; blocks the reuptake of serotonin (5HT) & norepinephrine (NE).
- is useful for concurrent conditions such as insomnia and depression

ADVERSE AFFECTS:
- anticholinergic (dry mouth, constipation, urinary retention in BPH, tachycardia)
- delirium
- orthostatic HYPOtension
- lower seizure threshold
- sexual dysfunction
- QT prolongation and cardiac arrhythmia

e.g. amitriptyline, nortripyline and desipramine

A

tricyclic antidepressants (TCA’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

this is a first line agent for managing neuropathic pain; decreases neuronal excitability

ADVERSE EFFECTS:
INCREASED RISK OF OVERDOSE WITH OPIOIDS
- weight gain
- edema
- cns sedation

A

GABA derivatives
- pregabalin (BID dosing/less CNS side effects)
- gabapentin (TID dosing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

this is a first line agent for managing neuropathic pain; blocks serotonin (5HT) and norepinephrine (NE). useful for concurrent conditions such as anxiety and depression

ADVERSE EFFECTS:
- GI
- sleep disturbance
- CNS drowsiness
- increase BP (at high doses)

e.g. duloxetine and venlafaxine
*duloxetine is also indicated for chronic low back pain and fibromyalgia

A

SNRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

this is a second line agent for managing neuropathic pain; metabolized by CYP 2D6 to active metabolite
- weak SNRI thus does not work that well for neuropathic pain; risk of serotonin syndrome!!
- weak mu receptor agonist thus risk of addiction, respiratory depression and cns adverse effects

A

Tramadol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

this is the drug of choice for Trigeminal neuralgia (severe facial pain) and is 4th line for chronic pain. it is a strong CYP450 inducer and autoinducer (metabolizes itself - drug works at first then stops working thus need to increase dose).

ADVERSE EFFECTS:
BONE MARROW SUPPRESSION and risk of infections (should get WBC’s checked
- hyponatremia
- hepatitis

A

carbamazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

this is a second line option for postherpetic neuralgia (common complication of shingles - burning pain of nerves and skin) and is fourth line for chronic pain. it is a sodium channel blocker. most effective for !!Localized!! neuropathic pain; minimal systemic absorption

supplied as an ung (apply TID-QID prn)

A

Topical anesthetics (topical lidocaine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

this is a fourth line option for managing neuropathic pain. is used for post-herpetic neuralgia and hand osteoarthritis. it acts by desensitizing pain receptors.
this medication is made from chili peppers therefore wear gloves or wash hands after application.
comes in strengths of 0.025%, 0.05% and 0.075%
AE: local burning, stinging and erythemia

A

topical capsaicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

this is a third line option for managing chronic neuropathic pain.
AE: dizziness, fatigue, nausea, euphoria, impaired memory, disturbance in attention, psychosis and addiction.
should start with a low dose of a non inhaled option

A

cannabinoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

cannabinoids are not recommended for those at high risk of major harms including:

A
  • have a history or a high risk of psychosis
  • have a history or high risk of substance use disorder
  • are pregnant or breastfeeding
  • are under the age of 21
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what are some options to manage neuropathic pain in pregnant women?

A

non pharm!!!!!
- acetaminophen
- NSAIDs (ibuprofen/naproxen) avoid in third trimester
- topical lidocaine (limited systemic absorption)
- amitriptyline
- try to avoid opioids, if only option use at lowest dose for shortest period of time due to neonatal withdrawal and rest. depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what should be the first recommendation when considering therapy for patients with chronic non-cancer pain?

A

We recommend optimization of non-opioid pharmacotherapy and non-pharmacological therapy first.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what should be the recommendation for patients with chronic non-cancer pain, without current or past substance use disorder and without other active psychiatric disorders, who have persistent problematic pain despite optimized nonopijoid therapy

A

we suggest ADDING a trial of opioids rather than continued therapy w/o opioids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

true/false: opioids are stimulants

A

false - opioids are depressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

this opioid should be avoided in renal insufficiency

A

morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

this opioid is 1.5x as potent as morphine. available in a tamper resistant formulation.

A

oxycodone

30
Q

this opioid is 5x as powerful as morphine. available in a tamper resistant formulation

A

hydromorphone

31
Q

this combination may minimize constipation and possibly act as an abuse deterrent

A

oxycodone/naloxone

32
Q

this opioid is good for the elderly due to less adverse effects; oral formulations are preferred over transdermal for initial trial

A

buprenorphine

33
Q

this is a prodrug (SNRI) that is converted to an opioid in a highly variable fashion

A

tramadol

34
Q

this is a dried extract from the poppy plant

A

opium

35
Q

this is naturally derived directly the opium poppy. examples include morphine and codeine.

A

opiates

36
Q

this is a broader class of agents; capable of producing opium-like effects or binding to opioid receptors

A

opioids

37
Q

this type of opioid has chemical modification. examples include heroin and oxycodone

A

semi-synthetic

38
Q

this type of opioid is a chemical compound capable of binding to an opioid receptor. examples include methadone, meperidine, fentanyl, carfenatil,

A

synthetic opioids

39
Q

what are the 3 different opioid receptors

A

mu, kappa and delta

40
Q

what are some results (adverse effects/what the drug is supposed to do) when the opioid receptors are activated by an opioid

A
  • pain relief & altered pain perception
  • N/V, constipation
  • respiratory depression
  • cough suppression
  • euphoria
  • sedation
  • miosis (constriction of pupil)
  • sweating
41
Q

what is maximum dose of morphine equivalents that should be prescribed for chronic non cancer pain?

A

90 mg morphine equivalents daily

42
Q

what are some of the expectations when starting an opioid?

A
  • ~ 30% reduction in pain
  • improved function
  • AE tolerable
  • prevent addiction
43
Q

What are the 4 A’s for monitoring opioids?

A

A - analgesia
A- Activity
A- Aberrant drug behaviour/adherence
A- Adverse effects

44
Q

this is described as the person needs more and more of the drug too produce the same effect

A

tolerance

45
Q

this is described as the endogenous opioid system activity is reduced to the point that the body becomes reliant on continued exogenous opioids

A

depends

46
Q

once a person is dependant on opioids, they will experience symptoms of ______ if they stop taking opioids

A

withdrawal

47
Q

this is known as the problematic use of a substance. it can range from mild (feeling hungover, being late for work) to severe (homelessness, disease)

A

addiction

48
Q

this should be done if a patient is having persistent problematic pain and/or adverse effects to an opioid

A

rotate to a different opioid

49
Q

when should opioid tapering/switching be considered?

A
  • lack of improvement in pain and/or function
  • non adherence to the treatment plan
  • opioid related complications (e.g. overdose, fall, or harm risk, hyperalgesia, adverse effects)
  • signs of substance misuse
  • patient request
50
Q

this is an increased sensitivity to pain; worsening pain despite dose increases.

A

hyperalgesia

51
Q

what is the general rule for tapering an opioid?

A

decrease dose by 5-10% every 2-4 weeks

52
Q

what is the general rule for switching between opioids?

A

decrease dose by 25-50% depending on the potency of the opioid, concomitant conditions/medications

53
Q

when tapering a patients opioid, should you taper the SR or IR formulation first?

A
  • this is usually patient preference
  • ideally you would want to taper the SR first so the patient still has a good strength of IR in case they experience any withdrawal symptoms while tapering the SR
54
Q

this is known as chronic widespread pain, increased tenderness, unrefreshing sleep, fatigue, cognitive dysfunction. this condition affects 2-4% of the population and of those affected, 80-90% are women; an increase in sensitivity over time. it is often associated with trauma or adverse life events such as abuse, neglect, bullying, etc.

A

fibromyalgia

55
Q

true/false: patients with fibromyalgia are more likely to have other conditions such as PTSD, depression, IBS and low back pain

A

true

56
Q

what is the first line for fibromyalgia

A

NON-PHARM!!
- physical exercise reduces pain
- medication and sleep hygeine
- stress management
- cognitive behaviour therapy

57
Q

true/false: opioids are effective for fibromyalgia and should be one of the first options considered for treatment

A

false

58
Q

this antidepressant improves sleep, reduces pain and fatigue in pts with fibromyalgia

A

TCA’s

59
Q

this antidepressant reduces pain (but does not help with sleep, fatigue, QOL) in pts with fibromyalgia

A

SNRI - duloxetine

60
Q

this antidepressant has minimal effect on pain and should usually only be considered if the patient has concomitant depression along with fibromyalgia

A

SSRI

61
Q

this class of medication is not effective in treating fibromyalgia

A

NSAIDs

62
Q

these medications improve pain scores and sleep in pts with fibromyalgia

A

gabapentinoids

63
Q

this medication is similar to TCA’s, but may help with sleep in pts with fibromyalgia

A

cyclobenzaprine (flexiril)

64
Q

what are some signs of opioid toxicity?

A
  • hypotension
  • arrhythmias
  • seizures
  • acute lung injury
65
Q

what are the 4 steps for managing an opioid overdose?

A
  1. supportive therapy: ABC’s, IV fluids and vasopressors, IV benzodiazepines for seizures
  2. GI decontamination: activated charcoal if early
  3. Remove source: consider source (patches, body packing)
  4. Administer antidote: naloxone
66
Q

this has a stronger affinity to the opioid receptors than the opioid so it knocks the opioids off the receptors for a short time; reverses respiratory and CNS depression and hypotension

A

naloxone

67
Q

approximately how long does naloxone reverse an opioid overdose for?

A

~ 30 MINS

68
Q

true/false: you only give one dose of naloxone when a person overdoses

A

false - give a dose of naloxone and then if the patient is still not breathing after 2-3 minutes give another dose. may have to repeat for the third time

69
Q

what are some harm reduction measures that can be implemented when a patient is on an opioid?

A
  • limit amount of opioid dispenses (max q month)
  • watch for aberrant drug-related behaviours
  • monitor for signs/symptoms of toxicity
  • careful during dose initiation, titration and switching
  • watch for risk factors: sleep apnea, renal dysfunction, older age
  • consider tamper resistant formulations
  • provide naloxone
  • fentanyl patch exchange
70
Q

list some aberrant drug-related behaviours indicative of opioid misuse

A
  • altering route of delivery (crushing, biting, injecting)
  • accessing opioids from other sources
  • drug seeking (early refills)
  • accompanying addictions
  • repeated withdrawal symptoms
  • social features (deteriorating or poor social function, concern expressed by family members)

pharmacotherapy 4270 (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions